the aid library

LIST OPTIONS

Filter

14820

Collection testing and transfusion kit 2021 (CTT kit 2021)

World Health Organization WHO (2021) C_WHO

To provide supply & equipment to collect, test and transfuse 50 blood bags. The new Collection testing and transfusion kit 2021 is specially designed for emergency settings where blood transfusion is crucial. It contains all the necessary supply & equipment needed to collect blood, test it agains... more

Download (258)

View PDF (395)

Home Care Guidance Update

World Health Organization WHO (2021) C_WHO

22 March 2021

Download (629)

View PDF (784)

Medicinal plants in Viet Nam

World Health Organization (WHO), Regional Office for the Western Pacific (1990) C_WHO

WHO regional publications. Western Pacific series ; no.3 The book has three main parts. The first part describes research in Viet Nam conducted on medicinal plants in line with the national policy of developing a system of medicine and pharmacy that integrates the modern and traditional systems. Th... more

Download (722)

View PDF (998)

Training of midwives in advanced obstetrics in Liberia

Obed Dolo, Alice Clack, Hannah Gibson, et al. World Health Organization (WHO) (2017) C_WHO

Download (960)

View PDF (2327)

Psychological first aid: Guide for field workers (Arabic version)
recommended

World Health Organization WHO, War Trauma Foundation and World Vision International (2011) C_WHO

لإسعافات الأولية النفسية: دليل العاملين في الميدان This guide covers psychological first aid which involves humane, supportive and practical help to fellow human beings suffering serious crisis events. It is written for people in a position to help other... more

Download (303)

View PDF (482)

Novel Coronavirus (2019-nCoV) advice for the public

World Health Organization WHO (2020) C1

WHO’s standard recommendations for the general public to reduce exposure to and transmission of a range of illnesses are as follows, which include hand and respiratory hygiene, and safe food practices. You can download a range of posters directly at the website

Download (372)

View PDF (332)

Интеграция совместного оказания услуг в связи с ТБ и ВИЧ во всеобъемлющий пакет помощи для потребителей инъекционных наркотиков

World Health Organization WHO, THE END TB STRATEGY (2016) C_WHO

В основе настоящих руководящих принципов лежит структура организации мероприятий в соответствии с тремя задачами: • создание и укрепление механизмов комплексно... more

External Link

Pneumonia kit 2020

World Health Organization WHO (2020) C_WHO

For 100 cases among which 60 cases of children ≥ 5 years old and 40 cases of children < 5 years old and adults. The new Pneumonia kit 2020 is specially designed to provide sufficient child-size antibiotics to treat pneumonia, targeting children under 5 years of age. It aims to provide life-savi... more

Download (522)

View PDF (1405)

Zika virus and the Olympic and Paralympic Games Rio 2016

World Health Organization WHO (2016) C_WHO

Download (401)

View PDF (647)

Strategy and plan of action on epilepsy

Pan American Health Organisation (PAHO) World Health Organization (WHO) (2011) C_WHO

Epilepsy is one of the world’s most common chronic neurological disorders. Roughly 50 million people suffer from it, 5 million of them in the Region of the Americas . Nevertheless, it is estimated that over 50% of these people in Latin America and the Caribbean have no access to services. Furthe... more

Download (376)

View PDF (608)

Epilepsy: slides

World Health Organization WHO (2015) C_WHO

Session outline •Introduction to epilepsy. •Assessment of epilepsy. •Management of epilepsy. •Follow-up of a person with epilepsy. •Review or materials and skills.

Download (417)

View PDF (445)

Self-harm/suicide: Powerpoint presentation slides (mhGAP)

World Health Organization WHO (2015) C_WHO

Session outline •Introduction to self-harm/suicide. •Assessment of self-harm/suicide. •Management of self-harm/suicide. •Follow-up.

Download (275)

View PDF (407)

Capacité juridique et droit à la décision – Formation de base de QualiyRights de l‘OMS-Services sociaux et de santé mentale

World Health Organisation (WHO) (2022) C_WHO

Les modules de formation et d’orientation QualityRights ont été élaborés pour renforcer les connaissances, les compétences et la compréhension des principales parties prenantes sur la manière de promouvoir les droits des personnes en situation de handicap psychosocial, intellectuel ou cogni... more

Download (454)

View PDF (451)

Maternal and fetal assessment update: imaging ultrasound before 24 weeks of pregnancy
recommended

World Health Organization WHO (2022) C_WHO

This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d... more

Download (266)

View PDF (589)

Response to the Ukraine Crisis: interim report, February to June 2022

World Health Organization WHO, Regional Office of Europe (2022) C_WHO

Saving lives is the priority of WHO’s response in Ukraine. WHO works to ensure time-critical, lifesaving multisectoral assistance, non-discriminatory access to emergency and essential health services and priority prevention programmes, and laying the foundation for longer-term health systems recov... more

Download (280)

View PDF (407)

Target product profile for a point-of-care diagnostic test for dermal leishmaniases - Control of Neglected Tropical Diseases

World Health Organization WHO (2022) C_WHO

Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani... more

Download (612)

View PDF (652)

Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile

World Health Organization WHO (2021) C_WHO

TARGET PRODUCT PROFILE

Download (482)

View PDF (959)

Diagnostic target product profiles for monitoring, evaluation and surveillance of schistosomiasis control programmes

World Health Organization WHO (2021) C_WHO

Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ... more

Download (467)

View PDF (695)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (314)

View PDF (259)

Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy

World Health Organization WHO (2022) C_WHO

WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi... more

Psychological first aid: Guide for field workers (Arabic version) recommended

Maternal and fetal assessment update: imaging ultrasound before 24 weeks of pregnancy recommended

Psychological first aid: Guide for field workers (Arabic version)
recommended

Maternal and fetal assessment update: imaging ultrasound before 24 weeks of pregnancy
recommended